Pro-Cure intends to become a leader in the development of therapeutics against cancer stem cells.
We believe that attacking the tumour-initiating cells will change the way in which cancer is treated and improve survivability whilst reducing recurrence.
We plan to leverage our core knowledge of the cell biology of cancer stem cells to progress from prostate into other cancers, discovering novel targets (and targets first found in prostate) in those tumour types and increasing the breadth of our drug pipeline.
